Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 26, 2007, doi:10.1212/01.wnl.0000280575.77437.a2)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000280575.77437.a2v1
70/7/512    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whitwell, J. L.
Right arrow Articles by Jack, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whitwell, J. L.
Right arrow Articles by Jack, C. R., Jr.
Received March 16, 2007
Accepted July 2, 2007

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

J. L. Whitwell PhD, M. M. Shiung BA, S. A. Przybelski BS, S. D. Weigand MS, D. S. Knopman MD, B. F Boeve MD, R. C. Petersen MD, and C. R. Jack Jr. MD

From the Departments of Radiology (J.L.W., M.M.S., C.R.J.), Biostatistics (S.A.P., S.D.W.), and Neurology (Behavioral Neurology) (D.S.K., B.F.B., R.C.P.), Mayo Clinic Rochester, MN.


ABSTRACT

Objective: To compare the patterns of gray matter loss in subjects with amnestic mild cognitive impairment (aMCI) who progress to Alzheimer disease (AD) within a fixed clinical follow-up time vs those who remain stable.

Methods: Twenty-one subjects with aMCI were identified from the Mayo Clinic Alzheimer’s research program who remained clinically stable for their entire observed clinical course (aMCI-S), where the minimum required follow-up time from MRI to last follow-up assessment was 3 years. These subjects were age- and gender-matched to 42 aMCI subjects who progressed to AD within 18 months of the MRI (aMCI-P). Each subject was then age- and gender-matched to a control subject. Voxel-based morphometry (VBM) was used to assess patterns of gray matter atrophy in the aMCI-P and aMCI-S groups compared to the control group, and compared to each other.

Results: The aMCI-P group showed bilateral loss affecting the medial and inferior temporal lobe, temporoparietal association neocortex, and frontal lobes, compared to controls. The aMCI-S group showed no regions of gray matter loss when compared to controls. When the aMCI-P and aMCI-S groups were compared directly, the aMCI-P group showed greater loss in the medial and inferior temporal lobes, the temporoparietal neocortex, posterior cingulate, precuneus, anterior cingulate, and frontal lobes than the aMCI-S group.

Conclusions: The regions of loss observed in subjects with amnestic mild cognitive impairment (aMCI) who progressed to Alzheimer disease (AD) within 18 months of the MRI are typical of subjects with AD. The lack of gray matter loss in subjects with aMCI who remained clinically stable for their entire observed clinical course is consistent with the notion that patterns of atrophy on MRI at baseline map well onto the subsequent clinical course.




This article has been cited by other articles:


Home page
Cereb CortexHome page
Y.-L. Chang, M. W. Jacobson, C. Fennema-Notestine, D. J. Hagler Jr, R. G. Jennings, A. M. Dale, L. K. McEvoy, and Alzheimer's Disease Neuroimaging Initiative
Level of Executive Function Influences Verbal Memory in Amnestic Mild Cognitive Impairment and Predicts Prefrontal and Posterior Cingulate Thickness
Cereb Cortex, September 23, 2009; (2009) bhp192v1.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. R. McDonald, L. K. McEvoy, L. Gharapetian, C. Fennema-Notestine, D. J. Hagler Jr, D. Holland, A. Koyama, J. B. Brewer, A. M. Dale, and For the Alzheimer's Disease Neuroimaging Initiativ
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease
Neurology, August 11, 2009; 73(6): 457 - 465.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. K. McEvoy, C. Fennema-Notestine, J. C. Roddey, D. J. Hagler Jr, D. Holland, D. S. Karow, C. J. Pung, J. B. Brewer, and A. M. Dale
Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment
Radiology, April 1, 2009; 251(1): 195 - 205.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Bakkour, J. C. Morris, and B. C. Dickerson
The cortical signature of prodromal AD: Regional thinning predicts mild AD dementia
Neurology, March 24, 2009; 72(12): 1048 - 1055.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. A. Rottenberg
Thin skin: The cortical signature of prodromal AD?
Neurology, March 24, 2009; 72(12): 1038 - 1039.
[Full Text] [PDF]


Home page
NeurologyHome page
W.J.P. Henneman, J. D. Sluimer, J. Barnes, W. M. van der Flier, I. C. Sluimer, N. C. Fox, P. Scheltens, H. Vrenken, and F. Barkhof
Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures
Neurology, March 17, 2009; 72(11): 999 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco, D. N. Greve, F. Grodstein, C. I. Wright, D. Blacker, H. D. Rosas, et al.
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Cereb Cortex, March 1, 2009; 19(3): 497 - 510.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. S. Desikan, B. Fischl, H. J. Cabral, T. L. Kemper, C.R.G. Guttmann, D. Blacker, B. T. Hyman, M. S. Albert, and R. J. Killiany
MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD
Neurology, September 9, 2008; 71(11): 819 - 825.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. Jagust
Is amnestic mild cognitive impairment always AD?
Neurology, February 12, 2008; 70(7): 502 - 503.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.